The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications

Orhan Şen

doi:10.53394/akd.1916102

EN TR

The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications

Abstract

Objective The global surge in minimally invasive aesthetic procedures has been paralleled by an unprecedented shift in patient digital health-seeking behaviour, catalysed by the public release of Large Language Models (LLMs) in November 2022. The infodemiological signature of this transition, particularly its impact on complication awareness and do-it-yourself (DIY) aesthetic practices remains uncharacterised at the population level. This study aimed to quantify the infodemiological impact of generative artificial intelligence (AI) adoption on patient digital search behaviour in aesthetic dermatology, comparing Pre-AI and Post-AI periods through a validated retrospective infodemiology framework. Material and Methods Relative Search Volume (RSV) data for 15 search terms across four categories were extracted from Google Trends (GT) under the "Health" category filter over an 84-month continuous time series (January 2019–December 2025). November 2022, corresponding to the global launch of ChatGPT (OpenAI, San Francisco, USA), served as the statistical cut-off, defining Pre-AI (January 2019–October 2022; n=46 months) and Post-AI (November 2022–December 2025; n=38 months) cohorts. Between-period RSV differences were assessed using the Mann-Whitney U test (SciPy library, Python Software Foundation, Wilmington, USA). Statistical significance was set at p<0.05. Results Post-AI searches for core aesthetic procedures rose modestly (botox: +29.9%, p<0.001; dermal filler: +23.4%, p=0.003), yet complication-related searches exhibited a markedly disproportionate surge: "dissolve filler" +122.7% (p<0.001) and "laser burn" +54.5% (p<0.001). Among DIY terms, "hyaluron pen" searches collapsed by 66.4% (p<0.001), whereas "microneedling infection" searches increased by 753.6% (p<0.001), reflecting a delayed complication burden from prior pandemic-era DIY practices. AI-related dermatology queries virtually non-existent in the Pre-AI period exhibited logarithmic growth exceeding 1000% (p<0.001). Conclusion The launch of generative LLMs constitutes a measurable "behavioural inflection point" in aesthetic dermatology. The asymmetric surge in complication-focused searches alongside declining device- and chemical-based DIY practices represents a paradigm shift in patient information-seeking behaviour rather than simple tool substitution. Dermatologists and health authorities must assume an active role in curating LLM-mediated aesthetic complication content and developing evidence-based digital health literacy strategies for the AI era.

Keywords

Supporting Institution

None

Ethical Statement

This study was conducted exclusively using publicly available, anonymised, de-identified, and aggregated digital data obtained from the Google Trends database. As the study contains no human subjects, living tissue, or personal health information (PHI), it is exempt from Ethics Committee approval and patient informed consent in accordance with national and international guidelines. All procedures were carried out in accordance with the ethical rules and the principles of the Declaration of Helsinki.

Thanks

None

Estetik Dermatolojide Davranışsal Dönüm Noktası: Üretken Yapay Zekanın İşlem Trendleri ve Önemli Komplikasyonlar Üzerindeki Etkisine Dair Küresel Bir İnfodemioloji Çalışması

Abstract

Amaç Minimal invaziv estetik prosedürlerdeki küresel artışa, Kasım 2022'de Büyük Dil Modellerinin (LLM'ler) halka açılmasının katalize ettiği, hastaların dijital sağlık arama davranışlarında benzeri görülmemiş bir değişim eşlik etmiştir. Bu geçişin infodemiyolojik imzası, özellikle komplikasyon farkındalığı ve kendin yap (DIY) estetik uygulamaları üzerindeki etkisi nüfus düzeyinde henüz karakterize edilmemiştir. Bu çalışma, onaylanmış bir retrospektif infodemiyoloji çerçevesi aracılığıyla yapay zeka öncesi ve sonrası dönemleri karşılaştırarak, üretken yapay zeka (AI) benimsenmesinin estetik dermatolojide hasta dijital arama davranışı üzerindeki infodemiyolojik etkisini ölçmeyi amaçlamıştır. Gereç ve Yöntemler Dört kategoriye ayrılmış 15 arama terimi için Göreceli Arama Hacmi (RSV) verileri, 84 aylık sürekli bir zaman serisi (Ocak 2019-Aralık 2025) boyunca "Sağlık" kategori filtresi altında Google Trends'ten (GT) çıkarılmıştır. ChatGPT'nin (OpenAI, San Francisco, ABD) küresel lansmanına karşılık gelen Kasım 2022 istatistiksel kesme noktası olarak hizmet etmiş ve Yapay Zeka Öncesi (Ocak 2019-Ekim 2022; n=46 ay) ve Yapay Zeka Sonrası (Kasım 2022-Aralık 2025; n=38 ay) kohortlarını tanımlamıştır. Dönemler arası RSV farklılıkları Mann-Whitney U testi (SciPy kütüphanesi, Python Software Foundation, Wilmington, ABD) kullanılarak değerlendirilmiştir. İstatistiksel anlamlılık p<0,05 olarak belirlenmiştir. Bulgular Temel estetik prosedürler için yapay zeka sonrası aramalar mütevazı bir artış göstermiştir (botoks: %29,9, p<0,001; dermal dolgu: +%23,4, p=0,003), ancak komplikasyonla ilgili aramalar belirgin şekilde orantısız bir artış sergilemiştir:"dolgu eritme" +%122,7 (p<0,001) ve "lazer yanığı" +%54,5 (p<0,001). DIY terimleri arasında, "hyaluron pen" aramaları %66,4 oranında çökerken (p<0,001), "mikroiğneleme enfeksiyonu" aramaları %753,6 oranında (p<0,001) artmış ve bu durum önceki pandemi dönemi DIY uygulamalarından kaynaklanan gecikmiş bir komplikasyon yükünü yansıtmıştır. Yapay zeka öncesi dönemdeneredeyse hiç var olmayan yapay zeka ile ilgili dermatoloji sorguları %1000'i aşan logaritmik bir büyüme sergilemiştir (p<0,001). Sonuç Üretken LLM'lerin piyasaya sürülmesi estetik dermatolojide ölçülebilir bir "davranışsal dönüm noktası" teşkil etmektedir. Cihaz ve kimyasal temelli DIY uygulamalarındaki azalmanın yanı sıra komplikasyon odaklı aramalardaki asimetrik artış, basit bir araç ikamesinden ziyade hastaların bilgi arama davranışlarında bir paradigma değişimini temsil etmektedir. Dermatologlar ve sağlık otoriteleri, LLM aracılı estetik komplikasyon içeriğinin küratörlüğünde aktif bir rol üstlenmeli ve yapay zeka çağı için kanıta dayalı dijital sağlık okuryazarlığı stratejileri geliştirmelidir.

Keywords

Supporting Institution

Yok

Ethical Statement

Bu çalışma, münhasıran Google Trends veritabanından elde edilen, halka açık, anonimleştirilmiş ve kimliksizleştirilmiş toplu dijital veriler kullanılarak yürütülmüştür. Çalışma; insan denek, canlı doku veya kişisel sağlık bilgileri (PHI) içermediği için ulusal ve uluslararası kılavuzlar uyarınca Etik Kurul onayı ve hasta bilgilendirilmiş onamından muaftır. Tüm süreçler, etik kurallara ve Helsinki Deklarasyonu ilkelerine uygun olarak gerçekleştirilmiştir.

Thanks

Yok

References

1. Meghe S, Ramapure R, Jaiswal S, Jawade S, Singh S. A comprehensive review of minimally invasive dermatosurgical procedures. Cureus. 2024;16(3):e56152.
2. Triana L, Palacios Huatuco RM, Campilgio G, Liscano E. Trends in surgical and nonsurgical aesthetic procedures: a 14-year analysis of the International Society of Aesthetic Plastic Surgery-ISAPS. Aesthetic Plast Surg. 2024;48(20):4217-27.
3. Alibudbud R. Google Trends for health research: its advantages, application, methodological considerations, and limitations in psychiatric and mental health infodemiology. Front Big Data. 2023;6:1132764.
4. Vourtsis SA, Alevrogianni K, Simou E. Aesthetic plastic surgery and dermatology medical procedures: the impact of internet and social media misinformation and the effect on public health. Aesthet Surg J. 2026:sjag023. doi:10.1093/asj/sjag023. Epub ahead of print.
5. Wang JV, Saedi N, Geronemus RG. Do-it-yourself cosmetic injectables in dermatology: high-risk, no reward. Dermatol Surg. 2021;47(7):1032-3.
6. Ali H, Qadir J, Alam T, Househ M, Shah Z. ChatGPT and large language models in healthcare: opportunities and risks. In: 2023 IEEE International Conference on Artificial Intelligence, Blockchain, and Internet of Things (AIBThings). IEEE; 2023. p. 1-4.
7. Tekchandani N, Mukherjee A, Poonthottam N, Boussios S. Comparative analysis of large language models in dermatological diagnosis: an evaluation of diagnostic accuracy. Cureus. 2025;17(9):e92089.
8. Eysenbach G. Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the Internet. J Med Internet Res. 2009;11(1):e11.

9. Mavragani A, Ochoa G. Google Trends in infodemiology and infoveillance: methodology framework. JMIR Public Health Surveill. 2019;5(2):e13439.
10. Sivesind TE, Szeto MD, Kim W, Dellavalle RP. Google Trends in dermatology: scoping review of the literature. JMIR Dermatol. 2021;4(1):e27712.
11. Motosko C, Zakhem G, Ho R, Saadeh P, Hazen A. Using Google to trend patient interest in botulinum toxin and hyaluronic acid fillers. J Drugs Dermatol. 2018;17(11):1245-6.
12. Liao D, Lee M, Shomorony A, Weitzman R, Sclafani AP. Zoom boom or bust? Understanding post-pandemic interest in facial plastic surgery via Google Trends. Laryngoscope. 2025;135(2):657-64.
13. Azzam DB, Dai YL, North VS, Callahan AB, Heher KL, Kapadia MK, Vagefi MR. Global surveillance of public interest in cosmetic tourism for aesthetic eyelid surgery abroad: cross-sectional infodemiology investigation of internet search trends and social media content. JMIR Infodemiology. 2025;5:e64639.
14. Ayo-Ajibola O, Davis RJ, Lin ME, Riddell J, Kravitz RL. Characterizing the adoption and experiences of users of artificial intelligence-generated health information in the United States: cross-sectional questionnaire study. J Med Internet Res. 2024;26:e55138.
15. Farishta D, Shires CB, Dewan K, Knackstedt M, Soleja R, Bundrick P, Bhuiyan MAN, Sanders K, Nathan CO. Trends in cosmetic facial plastic surgery post COVID-19 pandemic. Plast Reconstr Surg Glob Open. 2025;13(7):e6950.
16. Wang R, Li Y, Li Z, Yao H, Zhai Z. Hyaluronic acid filler-induced vascular occlusion-three case reports and overview of prevention and treatment. J Cosmet Dermatol. 2024;23(4):1217-23.
17. U.S. Food and Drug Administration. FDA executive summary: general issues panel meeting on dermal fillers [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2025 [cited 2026 Mar 20]. Available from: https://www.fda.gov/media/188185/download
18. Khalifian S, Vazirnia A, Mohan GC, Thompson KV, Jalian HR, Avram MM. Causes of injury and litigation in cutaneous laser surgery: an update from 2012 to 2020. Dermatol Surg. 2022;48(3):315-9.
19. Voelker R. Needle-free dermal filler injectors prompt safety warning. JAMA. 2021;326(19):1899.
20. Mehta N, Tyagi M, Ramam M, Khaitan BK. Cutaneous atypical mycobacterial infections: a brief review. Indian Dermatol Online J. 2024;15(6):909-19.
21. Kantor J. ChatGPT, large language models, and artificial intelligence in medicine and health care: a primer for clinicians and researchers. JAAD Int. 2023;13:168-9.
22. Goktas P, Grzybowski A. Assessing the impact of ChatGPT in dermatology: a comprehensive rapid review. J Clin Med. 2024;13(19):5909.
23. Yan S, Du D, Liu X, Dai Y, Kim MK, Zhou X, Wang L, Zhang L, Jiang X. Assessment of the reliability and clinical applicability of ChatGPT's responses to patients' common queries about rosacea. Patient Prefer Adherence. 2024;18:249-53.
24. Young JN, O'Hagan R, Poplausky D, Levoska MA, Gulati N, Ungar B, Ungar J. The utility of ChatGPT in generating patient-facing and clinical responses for melanoma. J Am Acad Dermatol. 2023;89(3):602-4.
25. De Angelis L, Baglivo F, Arzilli G, Privitera GP, Ferragina P, Tozzi AE, Rizzo C. ChatGPT and the rise of large language models: the new AI-driven infodemic threat in public health. Front Public Health. 2023;11:1166120.
26. Liu W, Wei Z, Cheng X, Pang R, Zhang H, Li G. Public interest in cosmetic surgical and minimally invasive plastic procedures during the COVID-19 pandemic: infodemiology study of Twitter data. J Med Internet Res. 2021;23(3):e23970.

Details

Primary Language

English

Subjects

Dermatology

Journal Section

Research Article

Authors

Orhan Şen ^*
0000-0002-8946-7330
Türkiye

Publication Date

September 30, 2026

Submission Date

March 25, 2026

Acceptance Date

July 3, 2026

Published in Issue

Year 2026 Volume: 12 Number: 1

DOI

https://doi.org/10.53394/akd.1916102

IZ

https://izlik.org/JA58ZG75EY

Cite

RIS / Bibtex

APA

Şen, O. (2026). The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications. Akdeniz Tıp Dergisi, 12(1). https://doi.org/10.53394/akd.1916102

AMA

1.Şen O. The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications. Akd Med J. 2026;12(1). doi:10.53394/akd.1916102

Chicago

Şen, Orhan. 2026. “The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications”. Akdeniz Tıp Dergisi 12 (1). https://doi.org/10.53394/akd.1916102.

EndNote

Şen O (September 1, 2026) The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications. Akdeniz Tıp Dergisi 12 1

IEEE

[1]O. Şen, “The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications”, Akd Med J, vol. 12, no. 1, Sept. 2026, doi: 10.53394/akd.1916102.

ISNAD

Şen, Orhan. “The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications”. Akdeniz Tıp Dergisi 12/1 (September 1, 2026). https://doi.org/10.53394/akd.1916102.

JAMA

1.Şen O. The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications. Akd Med J. 2026;12. doi:10.53394/akd.1916102.

MLA

Şen, Orhan. “The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications”. Akdeniz Tıp Dergisi, vol. 12, no. 1, Sept. 2026, doi:10.53394/akd.1916102.

Vancouver

1.Orhan Şen. The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications. Akd Med J. 2026 Sep. 1;12(1). doi:10.53394/akd.1916102

Akdeniz Medical Journal (AMJ; Akd Tıp D / Akd Med J) aims to contribute to the presentation, dissemination, and sharing of research conducted in the fields related to health sciences within national and international scientific communities, and in this context, to also contribute to the publicity of Türkiye.

The AMJ is freely accessible online by all relevant medical institutions and information centers in Türkiye and around the world. Our editorial board continues its efforts to increase the number of national and international indexes in which our journal is included.

AMJ is the official scientific publication of the Akdeniz University Faculty of Medicine, and is a peer-reviewed, interdisciplinary medical journal published in accordance with a continuous publication model. It is indexed in TÜBİTAK-ULAKBİM Turkish Medical Index, TürkMedline, Sobiad, Index Copernicus, and Academindex.

Primarily, original research articles (basic, clinical, and epidemiological) are considered for evaluation in AMJ. In addition, editorials, review articles, case reports, letters to the editor, technical notes, articles on medical education, articles on the history of medicine, biographies, etc., are also accepted. Submitted manuscripts must not have been previously published in written or electronic form, nor submitted to another journal or electronic platform for publication.

The ISSN number of AMJ during its print publication period was 1300-1779, and as of August 8, 2019, it has been changed to 2687-2781 as the journal continues its publication life electronically. The journal publishes in Turkish and English. In Turkish manuscripts, care should be taken to preserve the integrity of the Turkish language, and the latest editions of the Turkish Language Association’s Spelling Guide and Turkish Dictionary should be followed. Authors are encouraged to use Turkish scientific terminology as much as possible. For this purpose, authors may refer to the Turkish Language Association’s “Medical Terms Guide” or other medical terminology dictionaries.

AUTHOR GUIDELINES

Preparation of the Article and Writing Guidelines

Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (December 2021) prepared by the International Committee of Medical Journal Editors (ICMJE) (www.icmje.org) has been adopted in the preparation of the Akdeniz Medical Journal (AMJ; Akd Tıp D / Akd Med J) article writing rules.

General Principles

1.The articles submitted for publication in the journal should be written double-spaced with a 12-point Times New Roman font, leaving a 3-cm margin at sides.

2. Abbreviations should be written in full at their first occurrence in the text, followed by the abbreviation in parentheses. Unconventional abbreviations should not be used.

3. Numbers between one and ten in the text should be written in words (e.g., in both treatment groups, on the second day), whereas numbers 10 and above should be expressed in numerals. However, numbers between 1 and 10 that are used with a descriptive suffix should be written in numerals (e.g., 1 year), whereas numbers at the beginning of a sentence (e.g., Fifteen-year-old female patient) should be written in words.

4. The main and subheadings in the text should be written without numbering.

5. All pages should be numbered sequentially.

There is no specific word limit for original research and review articles; the appropriateness of the length will be evaluated on a case-by-case basis for each manuscript.

Case reports should be limited to 1,500 words, excluding the Abstract. Letters to the Editor may be submitted on various topics or regarding articles published in the journal, and responses from the authors may be requested. Letters to the Editor should not exceed 1,000 words, must not include tables or figures, and must be signed by all authors. The decision to publish such letters rests with the editor. Date, topic, and speaker announcements related to scientific meetings in the field of medicine may also be published. Manuscripts should be organized in the order specified below.

Title Page:

The Turkish and English titles of the manuscript, the names of the authors, their affiliations (institutions), academic titles, and contact information (e-mails and phone numbers), as well as the institution supporting the study, if applicable, should be provided. The internationally valid ORCID identifiers of all authors must be provided. If the manuscript has been previously presented at a scientific meeting, the name, place, and date of the meeting should be indicated. In addition, the name, surname, full address, phone and fax numbers, and e-mail address of the corresponding author must be clearly stated on this page.

Abstract:

The abstract should be prepared on a separate page in both Turkish (max. 250 words) and English (max. 300 words), including the headings. The abstract should accurately reflect the content of the manuscript, present the main findings, and include a brief interpretation of the results. Abbreviations that are not defined within the abstract should not be used, and references should not be cited in this section. Turkish and English abstracts should be structured as follows: Objective/Amaç; Method(s)/Yöntemler; Results/Bulgular; Conclusion(s)/Sonuç(lar)

Keywords:

Keywords in both Turkish and English should be provided in accordance with the Medical Subject Headings (MeSH) standards. A minimum of 3 and a maximum of 10 keywords should be listed below the Turkish and English abstracts of all manuscripts. It should be noted that keywords are among the most important elements for access to publications.

Sections:

Original research articles should include the following sections: Introduction; Materials and Methods (study design, case selection and description, technical information, statistical analysis, etc.); Results; Discussion; and Conclusion. Case reports should include Introduction, Case Presentation(s), Discussion, and Conclusion.

Following these sections, an Acknowledgments section may be included, if applicable, to recognize individuals who contributed to the research or the preparation of the manuscript. Acknowledgments should be placed at the end of the manuscript, before the References section. This section may include expressions of thanks for personal, technical, or material support.

References:

References should be listed at the end of the manuscript in the order in which they appear in the text and numbered accordingly. In-text citations should be indicated in parentheses. There should be no discrepancy between the order of references in the list and their order of citation in the text. Sources that have not been consulted in their original form but are cited through another source should not be numbered; in unavoidable cases, they may be indicated in parentheses. Authors are responsible for the accuracy of the references. All references must be cited in the text.

References should be formatted as shown in the examples below. All authors must be listed, without the use of “et al.”. Journal names should be abbreviated according to Index Medicus. Journal names not indexed in Index Medicus should not be abbreviated.

Examples for the Formatting of References:

For journals:

Muzaale AD, Massie AB, Wang MC, Montgomery RA , McBride MA , Wainright JL, Segev DL. Risk of end-stage renal disease following live kidney donation. JAMA 2014; 311:579-86.

For books:

Chabner ba, Longo DL: Cancer Chemotherapy and Biotherapy: Principles and Practice, 5th ed. Philadelphia, Lippincott Williams & Wilkins, 2011.

For chapters in books:

Goadsby PJ. Pathophysiology of headache. In: Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff ’s headache and other head pain. 7th ed. Oxford, England: Oxford University Press, 2001:57-72.

For conference papers:

Christensen S, Oppacher F. An analysis of Koza’s computational effort statistic for genetic programming. In: Foster JA, Lutton E, M iller J, Ryan C, Tettamanzi AG, editors. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.

For online articles:

U.S. Renal Data System. USRDS 2007 annual data report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 2007 (http://www.usrds.org/atlas07.aspx).

For journal supplements:

Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:1-138.

For Turkish references not indexed in Index Medicus, the above examples should be followed, with journal names written in full without abbreviation.

Tables

1.Tables should come after the References section, and each table should be presented on a separate page.

2. Tables should be numbered with Roman numerals in the order in which they appear in the text.

3. Table titles should be concise and placed above the table.

4. Table explanations and abbreviations should be placed below the table.

5.Each table must be referred to in the text.

6. The data presented in the tables should support the main text data and should not be a repetition of the data in the main text.

7. When using previously published tables, copyright permission should be obtained and should be stated in the table description. Writers have full legal, financial and penal responsibilities on these issues.

8.“Horizontal and vertical lines (grid lines) should not be used in tables. There should be only three horizontal lines: one above the table title, one below the column headings, and one at the bottom of the table (APA 7 table format). Vertical lines and cell borders should not be used under any circumstances.” 18.08.2026

An example table is provided below.

	Mean ± SD	Med (min - max)
STAI-I	21.60 ± 10.33	21 (30 - 80)
STAI-II	52.4 ± 9.4	60 (30 - 20)
BDI	20.19 ± 7.82	7 (0 - 60)
SD: Standard Deviation; Med: Median; Min – max: Minimum – maximum values. STAI-I: State-Trait Anxiety Inventory-I STAI-II: State-Trait Anxiety Inventory-II BDI: Beck Depression Inventory

Figures, Images and Graphics

Figures should be placed on a page separate from the text. The figures should either be drawn or photographed professionally or sent digitally in photo quality. The electronic files should be sent as high-resolution (pixel size 500x400 and 300 dpi resolution) electronic images, such as JPEG or GIF, and the authors should check the image quality of these files on the computer screen before sending. Symbols, arrows, and letters should contrast with the background. The staining techniques used in microscopy images and magnification must be specified. If a human image is used, either the person should not be recognized in the picture or written permission should be obtained (see ethics section). The figure and image legends should be placed at the bottom with Arabic numerals (1,2,3,....). The figures should be numbered according to their order in the text. Each figure should be referred to in the text.

Submission of Manuscripts to the Journal: Manuscripts should be submitted as electronic files written using Microsoft Word 2003 or later versions. A cover letter addressed to the editor should also be included, stating the type of the manuscript (original research, case report, review, etc.), the topic of the study, the contributions it will make to the literature, and how it fits within the scope of the journal. The signed “Copyright Transfer Form” from all authors is also among the required documents. Upon receipt of the manuscript, an article number will be assigned and communicated to the authors, and this number must be used in all correspondence. Manuscripts should follow the order below, and each section should begin on a new page:

1 Title page

2 Abstract

3 Text

4 Acknowledgements

5 References

6 Tables and Figures

All pages should be numbered consecutively. Below is a checklist provided to ensure that authors verify there are no missing items before submission.

Final Checklist:

Cover letter to the editor, including: manuscript category, study topic, contributions to the literature, how the manuscript fits the scope of the journal, statement confirming it has not been submitted to another journal, and disclosure of any sponsorship or commercial relationships.
Copyright Transfer Form
Document providing permission if previously published material (text, images, tables) has been used.
For studies involving human subjects, a statement in the “Materials and Methods” section confirming compliance with the principles of the Declaration of Helsinki, ethics committee approval, and informed consent from patients.
For studies involving animals, a statement in the “Materials and Methods” section confirming compliance with the “Guide for the Care and Use of Laboratory Animals”.
Cover page, including: the manuscript title in Turkish and English, authors and their affiliations, correspondence address, work and mobile phone numbers, and email addresses of all authors.
Öz (max. 250 words) and Abstract (max. 300 words)
Keywords: 3-10 (Turkish and English)
Acknowledgements
References
Tables and Figures

PRINCIPLES OF RESEARCH AND PUBLICATION ETHICS

Manuscripts submitted to the Akdeniz Medical Journal (AMJ) are expected to comply with the principles of research and publication ethics. For studies conducted on humans or animals, adherence to national and international ethical guidelines and approval from the relevant ethics committees are essential. The obtained “Ethics Committee Approval” must be uploaded online, together with the manuscript files, via https://dergipark.org.tr/tr/pub/akd. Authors are responsible for ensuring that their manuscripts comply with ethical standards.

Studies involving human subjects:

The journal requires that all studies involving human subjects comply with the World Medical Association (WMA) Declaration of Helsinki, the Good Clinical Practice Guidelines, the Good Laboratory Practice Guidelines, and the relevant regulations of the Republic of Türkiye Ministry of Health.

For research conducted on humans, obtaining approval from a Clinical Research Ethics Committee and submitting the relevant document to the journal are mandatory. Authors must state in the Materials and Methods section of the manuscript that they have obtained signed “informed consent” from the participants involved in the study or their legal representatives, as well as approval from the relevant ethics committee.

In case reports, regardless of whether the patient’s identity is disclosed, informed consent must be obtained from the patient or, when necessary, from their legal representative, and submitted to the journal. It should also be explicitly stated in the manuscript that this consent has been obtained.

Studies involving animal subjects:

For research conducted on animals, obtaining approval from an Experimental Animals Ethics Committee and submitting a copy of the relevant document to the journal are mandatory. In the Materials and Methods section of the manuscript, it must be stated that all animals in experimental studies were treated humanely in accordance with the Guide for the Care and Use of Laboratory Animals and that approval from the Animal Experiments Ethics Committee was obtained.

In studies involving animals, the measures taken to prevent pain, suffering, and distress must be clearly described. If a copy of the Ethics Committee approval is not submitted to the journal, the manuscript will not be considered for publication.

Permissions:
AMJ permits the sharing of published articles under the Creative Commons Attribution–NonCommercial–ShareAlike 4.0 International (Creative Commons; CC BY-NC-SA 4.0) license. Accordingly, authors and readers may copy, reproduce, and adapt the work, provided that appropriate credit is given, the material is not used for commercial purposes, and any adaptations are distributed under the same license. No copyright fee is paid for articles published in the journal.

Conflicts of interest:

Authors must disclose any conflicts of interest related to their manuscripts, if any. If there is any direct or indirect commercial relationship (such as employment, direct payments, stock ownership, company consultancy, patent licensing arrangements, or service fees, etc.) or financial support from an institution for the study, authors must declare that they have no commercial relationship with the commercial product, drug, company, etc. used in the study, or, if such a relationship exists, explain its nature. This declaration must be stated on the submission page and also included in the manuscript under the heading “Conflicts of Interest” before the References section.

Author contributions:

In manuscripts with multiple authors, the contributions of each author to the study (concept development, study design, experimental applications, statistical analysis, manuscript writing, etc.) must be specified and submitted to the editor with signatures (within the scope of the copyright transfer form). The author contribution statement must also be included in the manuscript before the References section.

Financial support:

All financial support, grants, and other contributions (including statistical analysis, English/Turkish language editing, and/or technical assistance) must be clearly stated in the manuscript before the References section. In addition, authors must declare the role of the sponsor(s), if any, in the following aspects: (1) study design, (2) data collection, analysis, and interpretation, (3) writing of the report, and (4) the decision to submit the manuscript for publication.

Plagiarism:

All manuscripts submitted to the journal are screened using iThenticate or Turnitin software before being considered for review, and a similarity report is obtained. The acceptable similarity rate for manuscripts is a maximum of 20%. Manuscripts exceeding this threshold will not be considered for evaluation. The AMJ Editorial Board acts in accordance with COPE guidelines in cases of allegations or suspicions of plagiarism, citation manipulation, or data fabrication.

ETHICAL RESPONSIBILITIES

All stakeholders involved in the production of a scientific study (authors, editors, reviewers, etc.) are expected to contribute to the proper advancement of science. In this regard, adherence to the principles of scientific ethics is of utmost importance in the preparation of scientific studies.

The principles adopted by the journal, some of which are outlined below, are recommended to be embraced by all stakeholders.

The editorial and publication processes of the journal are structured in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and the National Information Standards Organization (NISO). The journal has adopted the Principles of Transparency and Best Practice in Scholarly Publishing.

Ethical responsibilities of the authors

- To ensure the accuracy of data related to the study, to keep records of the research in an organized manner, and to provide access to these data upon reasonable request.

- To ensure that the submitted manuscript has not been published elsewhere and has not been accepted for publication.

- If the submitted content overlaps with previously published or submitted work, to acknowledge and cite this overlap. When necessary, to provide the editor with a copy of any related work that may have similar content. To obtain permission and provide proper citation for any content reproduced or used from other sources.

- To conduct studies involving human or animal subjects in accordance with national and international regulations and guidelines (e.g., the WMA Declaration of Helsinki, NRC Policy on the Use of Laboratory Animals, EU Directive on the Use of Experimental Animals), to indicate that the required approvals have been obtained, and to respect the privacy of subjects. To state the relevant ethics committee approvals and research details in the Materials and Methods section of the study.

- In case of any conflict of interest or if an ethical violation related to the manuscript is identified, to inform the editor and publisher, and, when necessary, to publish a correction, addendum, or retraction.

Ethical duties and responsibilities of the editors

- To perform their duties in a balanced, objective, and fair manner without discrimination based on authors’ gender, religious or political beliefs, ethnic or geographical origin.

- To evaluate submitted manuscripts based solely on their content and not to grant any privilege to any author.

- To take necessary measures to prevent potential conflicts of interest and to evaluate any existing declarations.

- To treat sponsored studies or studies on special topics in the same manner as other submissions.

- In case of complaints alleging ethical violations, to follow the journal’s policies and procedures, allow authors to respond, and apply necessary sanctions regardless of the identity of the authors.

- To reject manuscripts that are not in line with the aims and scope of the journal.

Ethical responsibilities of the reviewers

- To review manuscripts objectively and on time to contribute to the editor’s decision-making process, and to accept only those manuscripts that fall within their field of expertise.

- To evaluate manuscripts solely based on their content in an objective manner, independent of any religious, political, or economic interests.

- To provide guidance aimed at improving the quality of the manuscript and to review the work carefully. To communicate comments to the authors in a constructive and respectful manner.

- To maintain the confidentiality of the information provided by the editor and the authors, to destroy all copies of the manuscript and related files after the review process in accordance with confidentiality principles; to inform the editor of any breach of double-blind review, and to decline the review if necessary.

- To be aware of any potential conflicts of interest (financial, institutional, collaborative, or other relationships with the authors) and to notify the editor and withdraw from the review process when appropriate.

Examples of actions considered contrary to scientific research and publication ethics

- Plagiarism: Presenting others’ original ideas, methods, data, or works, in whole or in part, as one’s own without proper citation in accordance with scientific rules.

- Fabrication: Using data that do not exist or have been falsified in scientific research.

- Falsification: Manipulating research records or data; presenting devices or materials not used in the research as if they were used; distorting or shaping research results in line with the interests of supporting individuals or organizations.

- Duplicate publication: Presenting duplicate publications as separate works in academic appointments and promotions.

- Salami slicing: Inappropriately dividing the results of a study into multiple publications in a way that disrupts the integrity of the research and presenting them as separate publications for academic advancement.

- Unjust authorship: Including individuals who have not made an active contribution as authors, excluding those who have contributed, changing the order of authors without justification, removing contributors’ names in later editions, or adding individuals as authors despite lack of contribution by exploiting influence.

- Failure to acknowledge support: Not indicating the individuals, institutions, or organizations that provided support and their contributions in publications resulting from supported research.

- Unauthorized use of sources: Using theses or other unpublished or unapproved works as references without the permission of the owner.

- Non-compliance with ethical standards in human and animal research: Failing to follow ethical rules in studies involving humans and animals, not respecting patient rights, harming animal welfare or ecological balance, and not obtaining required permissions.

- Misuse of resources: Using resources, facilities, equipment, or funds allocated for scientific research for purposes other than intended.

- Misrepresentation: Making false or misleading statements regarding scientific research and publications in academic appointments and promotions.

Use of Generative Artificial Intelligence

Regarding the use of generative artificial intelligence (GenAI) in the preparation of manuscripts submitted to Akdeniz Medical Journal (AMJ) and in related scientific studies, the journal adheres to the principles outlined in the Ethics Guide of Generative Artificial Intelligence Use in the Scientific Research and Publication Process of Higher Education Institutions prepared by the Council of Higher Education of Türkiye (YÖK), as well as the principles defined by the World Association of Medical Editors (WAME) in Chatbots, Generative AI, and Scholarly Manuscripts.

The general guidelines of our journal regarding the use of GenAI are listed below:

· If GenAI has been used for purposes other than language editing and improvement, enhancing fluency, formatting, etc., during the preparation of manuscripts, this must be declared in the Methods section or another relevant part of the manuscript, as well as in the cover letter. Considering that GenAI platforms may provide incomplete, inaccurate, or misleading information, the necessary verification and validation procedures should be carried out. Authors are responsible for the validity of the GenAI platforms used in their research and/or manuscript preparation, as well as for the accuracy and ethical appropriateness of the outputs.

· GenAI platforms cannot be listed as authors of manuscripts or cited in the references.

· Articles may contain sensitive or confidential information that should not be shared outside the peer review process. For this reason, the use of GenAI platforms by reviewers during the peer-review process of manuscripts submitted to our journal is not considered appropriate.

Sample disclosure statement:

“This study utilized [NAME/VERSION OF THE GenAI PLATFORM] during the preparation of the manuscript for [PURPOSE OF USE]. The authors thoroughly reviewed the outputs generated by the platform that were incorporated into the manuscript and made corrections to the content where necessary. The authors accept full responsibility for all content generated with the assistance of GenAI in the published article.”

Publication Policy

Open access and publication processes

The Akdeniz Medical Journal (AMJ) provides open access to scientific publications. Full texts of all published issues and articles are freely available. No fees are charged to authors for the submission or publication of manuscripts. Readers may download journal content free of charge for academic or educational purposes. Open access is supported through the financial resources of Akdeniz University and the ongoing voluntary contributions of the editors and reviewers.

All scientific responsibility for the published work rests with the authors. The corresponding author is deemed to have accepted the order of authorship on behalf of all co-authors by completing and signing the “Author Responsibilities and Copyright Transfer Form.” Individuals who do not meet the criteria for authorship but have contributed to the study may be acknowledged in the “Acknowledgments” section. Authors must provide a signed statement declaring that the manuscript is original, has not been previously published, and will not be submitted elsewhere during the evaluation process.

Authors are deemed to have accepted any editorial revisions and corrections, provided that the scientific content is not altered. Submitted manuscripts are not returned, whether accepted or rejected; however, unpublished figures and images may be returned to the authors upon request. Manuscripts must be prepared in accordance with the journal’s guidelines and be ready for layout without deficiencies. The Editorial Board reserves the right to reject manuscripts that do not comply with the author guidelines, to return them to the authors for revision, or to make formal adjustments. Editors and language editors are fully authorized to make corrections related to language, spelling, and reference formatting, as well as other necessary editorial changes.

If the manuscript contains previously published text, tables, figures, or similar material, the corresponding author is responsible for obtaining written permission from the copyright holder and the original authors, and for indicating this in the manuscript.

Publication process and manuscript evaluation timeline

Manuscripts submitted to the AMJ are first reviewed by the Editorial Board through an objective preliminary evaluation. Editors reserve the right to reject manuscripts outright or to return them to the authors for revision. If no grounds for rejection are identified at this stage, the manuscript is sent to two independent reviewers with expertise in the relevant field.

Reviewers invited to evaluate a manuscript are expected to accept the invitation within a maximum of 7 days. A manuscript that receives two positive reviewer reports is eligible for publication. If one reviewer’s report is positive and the other is negative, the manuscript may be sent to a third reviewer; the final decision is made based on the reviewers’ reports and/or the editor’s judgment. Reviewers who accept the invitation are expected to complete their evaluation within a maximum of 30 days. If a reviewer declines the invitation or fails to submit a report within the specified time, a new reviewer is assigned.

Manuscripts are evaluated under a blind peer-review system; authors’ names are removed from the manuscript before being sent to reviewers. Authors are not informed about the identity of the reviewers. Reviewers and Editorial Board members may not discuss manuscripts publicly. In some cases, reviewer comments on a manuscript may be shared with other reviewers of the same manuscript by the editor for clarification purposes. If a reviewer fails to complete the evaluation within the given time, another reviewer may be assigned.

After completing their evaluation, reviewers submit their reports, including comments and recommendations, to the editor. If revisions are requested, the editor forwards the reviewers’ comments and suggestions to the authors and asks them to upload a revised version of the manuscript. Authors are given a maximum of 60 days to complete revisions. If a reviewer requests to re-evaluate the revised manuscript, it is sent back to the same reviewer. This process continues until the reviewers provide a final recommendation regarding acceptance or rejection. Reviewer reports are evaluated by the editor(s) within a maximum of 15 days, and the final decision is then communicated to the author(s).

The final decision for publication is made by the editor(s). Following layout and editorial corrections, the corresponding author is asked to perform a final check and provide written “approval for publication.” Manuscripts accepted for publication are expected to be published within 1–4 months under the continuous publication model. However, this timeframe may vary depending on factors such as the number of manuscripts awaiting publication, as well as the timeliness and originality of the work. No changes can be made to articles after publication.

Owner

YŞ

Yeşim ŞENOL

Adult Education, Public Health, Medical Education

Editor-in-Chief and Editor

AŞ

Ahter Dilşad ŞANLIOĞLU

Cell Development, Proliferation and Death, Gene Expression, Molecular Genetics, Animal Cell and Molecular Biology, Medical Genetics (Excl. Cancer Genetics), Gene and Molecular Therapy, Regenerative Medicine (Incl. Stem Cells)

Surgical Sciences Editor

İK

İsmail Türker KÖKSAL

Urology, Health Sciences

Clinical Sciences Editor

Aslıhan Yürüktümen ÜNAL

Emergency Medicine, Health Sciences

Basic Sciences Editor

Nuray ACAR AYDEMIR

Histology and Embryology, Health Sciences

Statistics Editor

Kemal Hakan GÜLKESEN

Biostatistics, Health Informatics and Information Systems

English Language Editors

Ceren HANGUL

Epigenetics, Medical Genetics (Excl. Cancer Genetics), Neurology and Neuromuscular Diseases, Health Sciences, Phytotherapy, Medicinal Plants, Traditional, Complementary and Integrative Medicine (Other)

Mustafa DALOĞLU

Otorhinolaryngology, Health Sciences, Medical Education

EM

Esvet MUTLU

Transplantation Immunology, Autoimmunity, Basic Immunology

Social Media, Index and Directory Editor

Ferit Onur MUTLUER

Cardiology

Turkish Language Editor

Serdal TEKELI

Health Sciences Education and Development of Programs: Medicine, Nursing and Health Sciences

Layout Editor

Ozden OZ

Graphic Design

Editorial Board

ME

Mahmut Cem ERGON

Bacteriology, Mycology, Medical Microbiology (Other)

ZB

Zeynep BAYKAN

Public Health, Preventative Health Care, Medical Education

AB

Ayşe Ergül BOZACI

Pediatric Metabolism Diseases

Emel GÜNDÜZ

Anaesthesiology

UÖ

Umut ÖZSOY

Anatomy, Biomechanics in Sports Science

Murat UÇAR

Pediatric Urology, Health Sciences

HÇ

Hasan ÇALIŞ

General Surgery

ÖÇ

Özlem ÇAKIN

Humoural Immunology and Immunochemistry, Intensive Care

Ferit Onur MUTLUER

Cardiology

SA

Sema ARAYICI

Infant and Child Health, Neonatology, Paediatrics (Other)

Selçuk YILMAZ

Orthopaedics

CK

Cüneyt Orhan KARA

Otorhinolaryngology, Medical Education

Hİ

Hatice Deniz İLHAN

Ophthalmology and Optometry, Ophthalmology, Ophthalmology and Optometry (Other)

MA

Mehmet Ali ASLANER

Emergency Medicine, Health Sciences

CB

Cumhur İbrahim BAŞSORGUN

Pathology

VD

Volkan DOĞRU

General Surgery

GG

Gökhan GÖRGIŞEN

Genomics, Molecular Genetics, Medical Genetics (Excl. Cancer Genetics), Cancer Genetics, Cancer Cell Biology, Cancer Diagnosis

DK

Dijle KIPMEN KORGUN

Cell Development, Proliferation and Death, Cell Metabolism, Receptors and Membrane Biology, Medical Biochemistry and Metabolomics

AT

Ayten TÜRKKANI

Histology and Embryology

AÇ

Aslı ÇAKIR ÇETIN

Otorhinolaryngology

AA

Ayşe Gülbin ARICI

Anaesthesiology

ÇA

Çağlayan Merve AYAZ CEYLAN

Infectious Agents

International Publication and Advisory Board

Melih ELÇIN

Family Medicine, Medical Education

PT

Piotr TRZONKOWSKI

Transplantation Immunology

Başak BILECEN

Sociology of Family and Relationships, Migration Sociology, Sociology of Health

Nadia EL ASMAR

Medical Education

Effie POLYZOGOPOULOU

Emergency Medicine

OA

Ozan AKCA

Anaesthesiology

Samir CAVADLI

Bacteriology, Mycology, Parasitology, Microbiology (Other), Infectious Diseases, Clinical Microbiology, Health Sciences Education and Development of Programs: Medicine, Nursing and Health Sciences, Medical Education

JM

Julina MD NOOR

Emergency Medicine

MG

Mehmet GÜLMEZ

General Surgery

SB

Selen BOZKURT

Knowledge Representation and Reasoning, Biomedical Sciences and Technology

	Sobiad
	TÜRK MEDLİNE
	INDEX COPERNICUS
	Academindex Türkiye
	Tr-Dizin
	Directory of Open Access Scholarly Resources
	Google Scholar

The Behavioral Inflection Point in Aesthetic Dermatology: A Global Infodemiology Study on the Impact of Generative Artificial Intelligence on Procedure Trends and Sentinel Complications

Abstract

Keywords

Supporting Institution

Ethical Statement

Thanks

Estetik Dermatolojide Davranışsal Dönüm Noktası: Üretken Yapay Zekanın İşlem Trendleri ve Önemli Komplikasyonlar Üzerindeki Etkisine Dair Küresel Bir İnfodemioloji Çalışması

Abstract

Keywords

Supporting Institution

Ethical Statement

Thanks

References

Details

Primary Language

Subjects

Journal Section

Authors

Publication Date

Submission Date

Acceptance Date

Published in Issue

DOI

IZ

Cite

Aim & Scope

Author Guidelines

Ethical Principles and Publication Policy

Price Policy

Indexes

Citation Indexes

Other Indexes

Journal Boards

Owner

Editor-in-Chief and Editor

Surgical Sciences Editor

Clinical Sciences Editor

Basic Sciences Editor

Statistics Editor

English Language Editors

Social Media, Index and Directory Editor

Turkish Language Editor

Layout Editor

Editorial Board

International Publication and Advisory Board